nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—ORM1—Vismodegib—skin cancer	0.155	0.185	CbGbCtD
Abiraterone—ORM1—Vemurafenib—skin cancer	0.123	0.146	CbGbCtD
Abiraterone—ABCC1—Vemurafenib—skin cancer	0.112	0.134	CbGbCtD
Abiraterone—ABCC1—Dactinomycin—skin cancer	0.0743	0.0888	CbGbCtD
Abiraterone—ALB—Vismodegib—skin cancer	0.0652	0.0779	CbGbCtD
Abiraterone—ALB—Vemurafenib—skin cancer	0.0516	0.0616	CbGbCtD
Abiraterone—CYP2C8—Vismodegib—skin cancer	0.0504	0.0602	CbGbCtD
Abiraterone—ABCC1—Docetaxel—skin cancer	0.0384	0.0458	CbGbCtD
Abiraterone—CYP3A4—Temozolomide—skin cancer	0.0295	0.0352	CbGbCtD
Abiraterone—CYP3A4—Imiquimod—skin cancer	0.0295	0.0352	CbGbCtD
Abiraterone—CYP2D6—Vemurafenib—skin cancer	0.0254	0.0304	CbGbCtD
Abiraterone—ALB—Fluorouracil—skin cancer	0.0232	0.0277	CbGbCtD
Abiraterone—Infectious pneumonitis—Bleomycin—skin cancer	0.0222	0.136	CcSEcCtD
Abiraterone—CYP3A4—Vismodegib—skin cancer	0.0204	0.0244	CbGbCtD
Abiraterone—CYP2C8—Fluorouracil—skin cancer	0.0179	0.0214	CbGbCtD
Abiraterone—CYP3A4—Vemurafenib—skin cancer	0.0162	0.0193	CbGbCtD
Abiraterone—Potassium low—Vismodegib—skin cancer	0.0135	0.083	CcSEcCtD
Abiraterone—Blood potassium decreased—Vismodegib—skin cancer	0.00746	0.0458	CcSEcCtD
Abiraterone—CYP3A4—Docetaxel—skin cancer	0.00555	0.00663	CbGbCtD
Abiraterone—Phosphatase alkaline increased—Vismodegib—skin cancer	0.00284	0.0174	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Vismodegib—skin cancer	0.00237	0.0145	CcSEcCtD
Abiraterone—Hepatotoxicity—Vemurafenib—skin cancer	0.00227	0.0139	CcSEcCtD
Abiraterone—Hypokalaemia—Vismodegib—skin cancer	0.00187	0.0115	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Vismodegib—skin cancer	0.00185	0.0114	CcSEcCtD
Abiraterone—Lymphopenia—Temozolomide—skin cancer	0.00175	0.0107	CcSEcCtD
Abiraterone—Sudden death—Fluorouracil—skin cancer	0.00161	0.00989	CcSEcCtD
Abiraterone—Hypercholesterolaemia—Imiquimod—skin cancer	0.00158	0.00969	CcSEcCtD
Abiraterone—Connective tissue disorder—Vismodegib—skin cancer	0.0014	0.00858	CcSEcCtD
Abiraterone—Hepatotoxicity—Dactinomycin—skin cancer	0.00128	0.00786	CcSEcCtD
Abiraterone—Lymphopenia—Docetaxel—skin cancer	0.00116	0.00714	CcSEcCtD
Abiraterone—Hepatotoxicity—Temozolomide—skin cancer	0.00116	0.00711	CcSEcCtD
Abiraterone—Cardiac failure—Imiquimod—skin cancer	0.00111	0.00682	CcSEcCtD
Abiraterone—Myalgia—Vismodegib—skin cancer	0.00106	0.00647	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00105	0.00643	CcSEcCtD
Abiraterone—Myocardial ischaemia—Fluorouracil—skin cancer	0.00103	0.00629	CcSEcCtD
Abiraterone—Skin disorder—Vismodegib—skin cancer	0.000983	0.00603	CcSEcCtD
Abiraterone—Infestation NOS—Vemurafenib—skin cancer	0.00098	0.00601	CcSEcCtD
Abiraterone—Infestation—Vemurafenib—skin cancer	0.00098	0.00601	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Vismodegib—skin cancer	0.000922	0.00565	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Temozolomide—skin cancer	0.000895	0.00549	CcSEcCtD
Abiraterone—Dyspepsia—Vismodegib—skin cancer	0.00089	0.00546	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Vismodegib—skin cancer	0.000873	0.00536	CcSEcCtD
Abiraterone—Fatigue—Vismodegib—skin cancer	0.000872	0.00535	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Imiquimod—skin cancer	0.000871	0.00534	CcSEcCtD
Abiraterone—Constipation—Vismodegib—skin cancer	0.000865	0.00531	CcSEcCtD
Abiraterone—Connective tissue disorder—Vemurafenib—skin cancer	0.000864	0.0053	CcSEcCtD
Abiraterone—Infestation NOS—Imiquimod—skin cancer	0.000836	0.00513	CcSEcCtD
Abiraterone—Infestation—Imiquimod—skin cancer	0.000836	0.00513	CcSEcCtD
Abiraterone—Acute coronary syndrome—Imiquimod—skin cancer	0.000824	0.00505	CcSEcCtD
Abiraterone—Myocardial infarction—Imiquimod—skin cancer	0.000819	0.00502	CcSEcCtD
Abiraterone—Cardiac disorder—Vemurafenib—skin cancer	0.000816	0.00501	CcSEcCtD
Abiraterone—Urinary tract infection—Imiquimod—skin cancer	0.000812	0.00498	CcSEcCtD
Abiraterone—Angiopathy—Vemurafenib—skin cancer	0.000798	0.0049	CcSEcCtD
Abiraterone—Mediastinal disorder—Vemurafenib—skin cancer	0.000793	0.00486	CcSEcCtD
Abiraterone—Hepatotoxicity—Docetaxel—skin cancer	0.000771	0.00473	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Temozolomide—skin cancer	0.000747	0.00458	CcSEcCtD
Abiraterone—Urinary tract disorder—Imiquimod—skin cancer	0.000741	0.00454	CcSEcCtD
Abiraterone—Myocardial ischaemia—Docetaxel—skin cancer	0.000741	0.00454	CcSEcCtD
Abiraterone—Connective tissue disorder—Imiquimod—skin cancer	0.000737	0.00452	CcSEcCtD
Abiraterone—Urethral disorder—Imiquimod—skin cancer	0.000735	0.00451	CcSEcCtD
Abiraterone—Asthenia—Vismodegib—skin cancer	0.000726	0.00445	CcSEcCtD
Abiraterone—Hot flush—Temozolomide—skin cancer	0.000695	0.00426	CcSEcCtD
Abiraterone—Diarrhoea—Vismodegib—skin cancer	0.000692	0.00425	CcSEcCtD
Abiraterone—Menopausal symptoms—Temozolomide—skin cancer	0.000689	0.00422	CcSEcCtD
Abiraterone—Angiopathy—Imiquimod—skin cancer	0.000681	0.00417	CcSEcCtD
Abiraterone—Mediastinal disorder—Imiquimod—skin cancer	0.000676	0.00415	CcSEcCtD
Abiraterone—Chest discomfort—Docetaxel—skin cancer	0.000673	0.00413	CcSEcCtD
Abiraterone—Arrhythmia—Imiquimod—skin cancer	0.00067	0.00411	CcSEcCtD
Abiraterone—Cough—Vemurafenib—skin cancer	0.000668	0.0041	CcSEcCtD
Abiraterone—Mental disorder—Imiquimod—skin cancer	0.000657	0.00403	CcSEcCtD
Abiraterone—Myalgia—Vemurafenib—skin cancer	0.000652	0.004	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.000647	0.00397	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Dactinomycin—skin cancer	0.000647	0.00397	CcSEcCtD
Abiraterone—Vomiting—Vismodegib—skin cancer	0.000643	0.00395	CcSEcCtD
Abiraterone—Rash—Vismodegib—skin cancer	0.000638	0.00391	CcSEcCtD
Abiraterone—Dermatitis—Vismodegib—skin cancer	0.000637	0.00391	CcSEcCtD
Abiraterone—Infection—Vemurafenib—skin cancer	0.000621	0.00381	CcSEcCtD
Abiraterone—Cardiac failure—Fluorouracil—skin cancer	0.000613	0.00376	CcSEcCtD
Abiraterone—Skin disorder—Vemurafenib—skin cancer	0.000607	0.00372	CcSEcCtD
Abiraterone—Pneumonia—Bleomycin—skin cancer	0.000597	0.00366	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Docetaxel—skin cancer	0.000595	0.00365	CcSEcCtD
Abiraterone—Hypokalaemia—Temozolomide—skin cancer	0.000591	0.00363	CcSEcCtD
Abiraterone—Acute coronary syndrome—Bleomycin—skin cancer	0.000585	0.00359	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.000585	0.00359	CcSEcCtD
Abiraterone—Myocardial infarction—Bleomycin—skin cancer	0.000582	0.00357	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Temozolomide—skin cancer	0.000573	0.00352	CcSEcCtD
Abiraterone—Cough—Imiquimod—skin cancer	0.00057	0.0035	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000569	0.00349	CcSEcCtD
Abiraterone—Haematuria—Bleomycin—skin cancer	0.000566	0.00347	CcSEcCtD
Abiraterone—Fluid retention—Docetaxel—skin cancer	0.000565	0.00347	CcSEcCtD
Abiraterone—Hypertension—Imiquimod—skin cancer	0.000564	0.00346	CcSEcCtD
Abiraterone—Pneumonia—Dactinomycin—skin cancer	0.000557	0.00342	CcSEcCtD
Abiraterone—Myalgia—Imiquimod—skin cancer	0.000556	0.00341	CcSEcCtD
Abiraterone—Chest pain—Imiquimod—skin cancer	0.000556	0.00341	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000552	0.00339	CcSEcCtD
Abiraterone—Discomfort—Imiquimod—skin cancer	0.000549	0.00337	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00054	0.00331	CcSEcCtD
Abiraterone—Fatigue—Vemurafenib—skin cancer	0.000539	0.00331	CcSEcCtD
Abiraterone—Nasopharyngitis—Fluorouracil—skin cancer	0.000535	0.00328	CcSEcCtD
Abiraterone—Constipation—Vemurafenib—skin cancer	0.000534	0.00328	CcSEcCtD
Abiraterone—Oedema—Imiquimod—skin cancer	0.000533	0.00327	CcSEcCtD
Abiraterone—Infection—Imiquimod—skin cancer	0.000529	0.00325	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Temozolomide—skin cancer	0.000522	0.0032	CcSEcCtD
Abiraterone—Pollakiuria—Temozolomide—skin cancer	0.000519	0.00318	CcSEcCtD
Abiraterone—Skin disorder—Imiquimod—skin cancer	0.000518	0.00318	CcSEcCtD
Abiraterone—Hyperglycaemia—Temozolomide—skin cancer	0.000507	0.00311	CcSEcCtD
Abiraterone—Pneumonia—Temozolomide—skin cancer	0.000504	0.00309	CcSEcCtD
Abiraterone—Infestation—Temozolomide—skin cancer	0.000501	0.00307	CcSEcCtD
Abiraterone—Infestation NOS—Temozolomide—skin cancer	0.000501	0.00307	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.000497	0.00305	CcSEcCtD
Abiraterone—Body temperature increased—Vemurafenib—skin cancer	0.000494	0.00303	CcSEcCtD
Abiraterone—Urinary tract infection—Temozolomide—skin cancer	0.000487	0.00299	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000486	0.00298	CcSEcCtD
Abiraterone—Insomnia—Imiquimod—skin cancer	0.000482	0.00296	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000481	0.00295	CcSEcCtD
Abiraterone—Dyspnoea—Imiquimod—skin cancer	0.000475	0.00291	CcSEcCtD
Abiraterone—Dyspepsia—Imiquimod—skin cancer	0.000469	0.00288	CcSEcCtD
Abiraterone—Pneumonia—Fluorouracil—skin cancer	0.000464	0.00285	CcSEcCtD
Abiraterone—Hot flush—Docetaxel—skin cancer	0.000462	0.00283	CcSEcCtD
Abiraterone—Infestation NOS—Fluorouracil—skin cancer	0.000461	0.00283	CcSEcCtD
Abiraterone—Infestation—Fluorouracil—skin cancer	0.000461	0.00283	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Imiquimod—skin cancer	0.00046	0.00282	CcSEcCtD
Abiraterone—Fatigue—Imiquimod—skin cancer	0.000459	0.00282	CcSEcCtD
Abiraterone—Menopausal symptoms—Docetaxel—skin cancer	0.000458	0.00281	CcSEcCtD
Abiraterone—Acute coronary syndrome—Fluorouracil—skin cancer	0.000455	0.00279	CcSEcCtD
Abiraterone—Myocardial infarction—Fluorouracil—skin cancer	0.000452	0.00277	CcSEcCtD
Abiraterone—Urinary tract infection—Fluorouracil—skin cancer	0.000448	0.00275	CcSEcCtD
Abiraterone—Asthenia—Vemurafenib—skin cancer	0.000448	0.00275	CcSEcCtD
Abiraterone—Urinary tract disorder—Temozolomide—skin cancer	0.000444	0.00272	CcSEcCtD
Abiraterone—Cardiac failure—Docetaxel—skin cancer	0.000443	0.00272	CcSEcCtD
Abiraterone—Connective tissue disorder—Temozolomide—skin cancer	0.000442	0.00271	CcSEcCtD
Abiraterone—Urethral disorder—Temozolomide—skin cancer	0.000441	0.0027	CcSEcCtD
Abiraterone—Anaemia—Bleomycin—skin cancer	0.000429	0.00263	CcSEcCtD
Abiraterone—Diarrhoea—Vemurafenib—skin cancer	0.000428	0.00262	CcSEcCtD
Abiraterone—Body temperature increased—Imiquimod—skin cancer	0.000421	0.00258	CcSEcCtD
Abiraterone—Cardiac disorder—Temozolomide—skin cancer	0.000417	0.00256	CcSEcCtD
Abiraterone—Angiopathy—Temozolomide—skin cancer	0.000408	0.0025	CcSEcCtD
Abiraterone—Mediastinal disorder—Temozolomide—skin cancer	0.000405	0.00249	CcSEcCtD
Abiraterone—Cough—Bleomycin—skin cancer	0.000405	0.00248	CcSEcCtD
Abiraterone—Anaemia—Dactinomycin—skin cancer	0.0004	0.00245	CcSEcCtD
Abiraterone—Vomiting—Vemurafenib—skin cancer	0.000397	0.00244	CcSEcCtD
Abiraterone—Chest pain—Bleomycin—skin cancer	0.000395	0.00242	CcSEcCtD
Abiraterone—Myalgia—Bleomycin—skin cancer	0.000395	0.00242	CcSEcCtD
Abiraterone—Rash—Vemurafenib—skin cancer	0.000394	0.00242	CcSEcCtD
Abiraterone—Mental disorder—Temozolomide—skin cancer	0.000394	0.00242	CcSEcCtD
Abiraterone—Dermatitis—Vemurafenib—skin cancer	0.000394	0.00241	CcSEcCtD
Abiraterone—Discomfort—Bleomycin—skin cancer	0.00039	0.00239	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000389	0.00239	CcSEcCtD
Abiraterone—Nasopharyngitis—Docetaxel—skin cancer	0.000386	0.00237	CcSEcCtD
Abiraterone—Asthenia—Imiquimod—skin cancer	0.000382	0.00235	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000381	0.00234	CcSEcCtD
Abiraterone—Oedema—Bleomycin—skin cancer	0.000379	0.00232	CcSEcCtD
Abiraterone—Infection—Bleomycin—skin cancer	0.000376	0.00231	CcSEcCtD
Abiraterone—Arrhythmia—Fluorouracil—skin cancer	0.00037	0.00227	CcSEcCtD
Abiraterone—Myalgia—Dactinomycin—skin cancer	0.000368	0.00226	CcSEcCtD
Abiraterone—Diarrhoea—Imiquimod—skin cancer	0.000365	0.00224	CcSEcCtD
Abiraterone—Discomfort—Dactinomycin—skin cancer	0.000364	0.00223	CcSEcCtD
Abiraterone—Anaemia—Temozolomide—skin cancer	0.000362	0.00222	CcSEcCtD
Abiraterone—Oedema—Dactinomycin—skin cancer	0.000353	0.00217	CcSEcCtD
Abiraterone—Infection—Dactinomycin—skin cancer	0.000351	0.00215	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000345	0.00212	CcSEcCtD
Abiraterone—Cough—Temozolomide—skin cancer	0.000341	0.00209	CcSEcCtD
Abiraterone—Vomiting—Imiquimod—skin cancer	0.000339	0.00208	CcSEcCtD
Abiraterone—Hypertension—Temozolomide—skin cancer	0.000338	0.00207	CcSEcCtD
Abiraterone—Dyspnoea—Bleomycin—skin cancer	0.000338	0.00207	CcSEcCtD
Abiraterone—Rash—Imiquimod—skin cancer	0.000336	0.00206	CcSEcCtD
Abiraterone—Dermatitis—Imiquimod—skin cancer	0.000336	0.00206	CcSEcCtD
Abiraterone—Pneumonia—Docetaxel—skin cancer	0.000335	0.00205	CcSEcCtD
Abiraterone—Anaemia—Fluorouracil—skin cancer	0.000333	0.00204	CcSEcCtD
Abiraterone—Myalgia—Temozolomide—skin cancer	0.000333	0.00204	CcSEcCtD
Abiraterone—Infestation NOS—Docetaxel—skin cancer	0.000333	0.00204	CcSEcCtD
Abiraterone—Infestation—Docetaxel—skin cancer	0.000333	0.00204	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000331	0.00203	CcSEcCtD
Abiraterone—Discomfort—Temozolomide—skin cancer	0.000329	0.00202	CcSEcCtD
Abiraterone—Acute coronary syndrome—Docetaxel—skin cancer	0.000328	0.00201	CcSEcCtD
Abiraterone—Myocardial infarction—Docetaxel—skin cancer	0.000326	0.002	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000322	0.00197	CcSEcCtD
Abiraterone—Oedema—Temozolomide—skin cancer	0.000319	0.00196	CcSEcCtD
Abiraterone—Infection—Temozolomide—skin cancer	0.000317	0.00195	CcSEcCtD
Abiraterone—Skin disorder—Temozolomide—skin cancer	0.00031	0.0019	CcSEcCtD
Abiraterone—Myalgia—Fluorouracil—skin cancer	0.000307	0.00188	CcSEcCtD
Abiraterone—Chest pain—Fluorouracil—skin cancer	0.000307	0.00188	CcSEcCtD
Abiraterone—Fatigue—Dactinomycin—skin cancer	0.000304	0.00187	CcSEcCtD
Abiraterone—Discomfort—Fluorouracil—skin cancer	0.000303	0.00186	CcSEcCtD
Abiraterone—Body temperature increased—Bleomycin—skin cancer	0.000299	0.00184	CcSEcCtD
Abiraterone—Urinary tract disorder—Docetaxel—skin cancer	0.000295	0.00181	CcSEcCtD
Abiraterone—Oedema—Fluorouracil—skin cancer	0.000294	0.00181	CcSEcCtD
Abiraterone—Connective tissue disorder—Docetaxel—skin cancer	0.000294	0.0018	CcSEcCtD
Abiraterone—Urethral disorder—Docetaxel—skin cancer	0.000293	0.0018	CcSEcCtD
Abiraterone—Infection—Fluorouracil—skin cancer	0.000292	0.00179	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000291	0.00178	CcSEcCtD
Abiraterone—Insomnia—Temozolomide—skin cancer	0.000289	0.00177	CcSEcCtD
Abiraterone—Dyspnoea—Temozolomide—skin cancer	0.000285	0.00175	CcSEcCtD
Abiraterone—Dyspepsia—Temozolomide—skin cancer	0.000281	0.00172	CcSEcCtD
Abiraterone—Body temperature increased—Dactinomycin—skin cancer	0.000279	0.00171	CcSEcCtD
Abiraterone—Cardiac disorder—Docetaxel—skin cancer	0.000277	0.0017	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Temozolomide—skin cancer	0.000276	0.00169	CcSEcCtD
Abiraterone—Fatigue—Temozolomide—skin cancer	0.000275	0.00169	CcSEcCtD
Abiraterone—Constipation—Temozolomide—skin cancer	0.000273	0.00168	CcSEcCtD
Abiraterone—Asthenia—Bleomycin—skin cancer	0.000272	0.00167	CcSEcCtD
Abiraterone—Angiopathy—Docetaxel—skin cancer	0.000271	0.00166	CcSEcCtD
Abiraterone—Mediastinal disorder—Docetaxel—skin cancer	0.000269	0.00165	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000268	0.00164	CcSEcCtD
Abiraterone—Arrhythmia—Docetaxel—skin cancer	0.000267	0.00164	CcSEcCtD
Abiraterone—Insomnia—Fluorouracil—skin cancer	0.000266	0.00163	CcSEcCtD
Abiraterone—Dyspnoea—Fluorouracil—skin cancer	0.000262	0.00161	CcSEcCtD
Abiraterone—Mental disorder—Docetaxel—skin cancer	0.000262	0.00161	CcSEcCtD
Abiraterone—Dyspepsia—Fluorouracil—skin cancer	0.000259	0.00159	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000254	0.00156	CcSEcCtD
Abiraterone—Asthenia—Dactinomycin—skin cancer	0.000253	0.00155	CcSEcCtD
Abiraterone—Body temperature increased—Temozolomide—skin cancer	0.000252	0.00155	CcSEcCtD
Abiraterone—Diarrhoea—Dactinomycin—skin cancer	0.000242	0.00148	CcSEcCtD
Abiraterone—Vomiting—Bleomycin—skin cancer	0.000241	0.00148	CcSEcCtD
Abiraterone—Anaemia—Docetaxel—skin cancer	0.000241	0.00148	CcSEcCtD
Abiraterone—Rash—Bleomycin—skin cancer	0.000239	0.00146	CcSEcCtD
Abiraterone—Dermatitis—Bleomycin—skin cancer	0.000238	0.00146	CcSEcCtD
Abiraterone—Body temperature increased—Fluorouracil—skin cancer	0.000233	0.00143	CcSEcCtD
Abiraterone—Asthenia—Temozolomide—skin cancer	0.000229	0.00141	CcSEcCtD
Abiraterone—Cough—Docetaxel—skin cancer	0.000227	0.00139	CcSEcCtD
Abiraterone—Hypertension—Docetaxel—skin cancer	0.000225	0.00138	CcSEcCtD
Abiraterone—Vomiting—Dactinomycin—skin cancer	0.000225	0.00138	CcSEcCtD
Abiraterone—Rash—Dactinomycin—skin cancer	0.000223	0.00137	CcSEcCtD
Abiraterone—Chest pain—Docetaxel—skin cancer	0.000222	0.00136	CcSEcCtD
Abiraterone—Myalgia—Docetaxel—skin cancer	0.000222	0.00136	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00022	0.00135	CcSEcCtD
Abiraterone—Diarrhoea—Temozolomide—skin cancer	0.000219	0.00134	CcSEcCtD
Abiraterone—Oedema—Docetaxel—skin cancer	0.000212	0.0013	CcSEcCtD
Abiraterone—Infection—Docetaxel—skin cancer	0.000211	0.00129	CcSEcCtD
Abiraterone—Skin disorder—Docetaxel—skin cancer	0.000206	0.00127	CcSEcCtD
Abiraterone—Vomiting—Temozolomide—skin cancer	0.000203	0.00125	CcSEcCtD
Abiraterone—Rash—Temozolomide—skin cancer	0.000201	0.00124	CcSEcCtD
Abiraterone—Diarrhoea—Fluorouracil—skin cancer	0.000201	0.00124	CcSEcCtD
Abiraterone—Dermatitis—Temozolomide—skin cancer	0.000201	0.00123	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000194	0.00119	CcSEcCtD
Abiraterone—Insomnia—Docetaxel—skin cancer	0.000192	0.00118	CcSEcCtD
Abiraterone—Dyspnoea—Docetaxel—skin cancer	0.000189	0.00116	CcSEcCtD
Abiraterone—Vomiting—Fluorouracil—skin cancer	0.000187	0.00115	CcSEcCtD
Abiraterone—Dyspepsia—Docetaxel—skin cancer	0.000187	0.00115	CcSEcCtD
Abiraterone—Rash—Fluorouracil—skin cancer	0.000186	0.00114	CcSEcCtD
Abiraterone—Dermatitis—Fluorouracil—skin cancer	0.000185	0.00114	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Docetaxel—skin cancer	0.000183	0.00112	CcSEcCtD
Abiraterone—Fatigue—Docetaxel—skin cancer	0.000183	0.00112	CcSEcCtD
Abiraterone—Constipation—Docetaxel—skin cancer	0.000182	0.00111	CcSEcCtD
Abiraterone—Body temperature increased—Docetaxel—skin cancer	0.000168	0.00103	CcSEcCtD
Abiraterone—Asthenia—Docetaxel—skin cancer	0.000152	0.000935	CcSEcCtD
Abiraterone—Diarrhoea—Docetaxel—skin cancer	0.000145	0.000891	CcSEcCtD
Abiraterone—Vomiting—Docetaxel—skin cancer	0.000135	0.000828	CcSEcCtD
Abiraterone—Rash—Docetaxel—skin cancer	0.000134	0.000821	CcSEcCtD
Abiraterone—Dermatitis—Docetaxel—skin cancer	0.000134	0.000821	CcSEcCtD
